NCT06082947View on ClinicalTrials.gov

αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2023

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2030

Conditions

Hematopoietic Stem Cell TransplantationHematologic Malignancy

Interventions

DEVICE

CliniMACS®

CliniMACS® αβT cell/CD19+B cell depletion device for Children and Young Adults with Hematologic Malignancies undergoing alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)

Trial Locations (1)

43205

RECRUITING

Nationwide Children's Hospital, Columbus

All Listed Sponsors

lead

Nationwide Children's Hospital

OTHER